Rohto Pharmaceutical (4527) · FactAdvanced
Issuance of shares through the exercise of share acquisition rights
First written in FY2020-Q1. 1 of 2 entries say "Advanced", first in FY2020. Latest entry: FY2020.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Increase in shares, capital and other items through the exercise of stock optionsA theme 9 companies write about · 0 as a headwind · 8 as a tailwind
4 other companies' latest entry also says "Advanced".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2020AdvancedAnnual report
「1 April 2019–31 March 2020 99,247 118,089,155 57 6,504 57 5,607」
In FY2020, the exercise of stock options increased the number of shares by 99,247 and increased stated capital and the capital reserve by ¥57 million each. - FY2020-Q1First statedAnnual report
「Between 1 July 2019 and 31 July 2019, the exercise of share acquisition rights increased the total number of shares issued by 99,247 shares and increased stated capital and the capital reserve by ¥57 each.」
The exercise of share acquisition rights in July 2019 increased the total number of shares issued by 99,247 shares and increased stated capital and the capital reserve by ¥57 each.